<p>Expression of Carboxypeptidase X M14 Family Member 2 Accelerates the Progression of Hepatocellular Carcinoma via Regulation of the gp130/JAK2/Stat1 Pathway</p>-Reference-Cited by-同舟云学术

Expression of Carboxypeptidase X M14 Family Member 2 Accelerates the Progression of Hepatocellular Carcinoma via Regulation of the gp130/JAK2/Stat1 Pathway

Published:2020-03 Issue: Volume:Volume 12 Page:2353-2364
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Ye Yanshuo,An Yuan,Wang Min,Liu Hongyu,Guan Lianyue,Wang Zhanpeng,Li Wei

Publisher

Informa UK Limited

Subject

Oncology

Reference29 articles.

1. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma

2. Conditional survival of patients with hepatocellular carcinoma: results from the Surveillance, Epidemiology, and End Results registry

3. Epidemiology and Management of Hepatocellular Carcinoma

4. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis

5. Specificity of Carboxypeptidases from Actinomucor elegans and Their Debittering Effect on Soybean Protein Hydrolysates

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inactive metallopeptidase homologs: the secret lives of pseudopeptidases;Frontiers in Molecular Biosciences;2024-07-10

2. RNA-sequencing expression profile and functional analysis of retinal pigment epithelium in atrophic age-related macular degeneration;The Journal of Biomedical Research;2024

3. Proteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues;Nature Communications;2022-07-18

4. Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma;Frontiers in Oncology;2022-05-23

5. Morphine Prevents Ischemia/Reperfusion-Induced Myocardial Mitochondrial Damage by Activating δ-opioid Receptor/EGFR/ROS Pathway;Cardiovascular Drugs and Therapy;2021-07-19